SIRPG and cancer: We demonstrate in this study that SIRPγhi lung tumor cells represent unique CSLCs, which are critical for tumorigenesis and metastasis through activating YAP signaling, and that targeting SIRPγ by genetic and pharmacological approaches markedly inhibits lung tumor growth in xenograft, genetic, and PDX models, as well as growth of cancer organoids.